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Langerhans cells (LC) have been implicated as anti-
gen-presenting and target cells in contact allergic, cell-
mediated reactions. We have examined the effects in 
guinea pigs, rats, and humans of in situ (epicutaneous) 
exposure to glucocorticosteroids (GCS) on the expres-
sion of epidermal LC markers. Reductions in the number 
of Fc-rosetting, C3b-rosetting, and immune-associated 
(Ia) antigen-bearing LC occurred in a dose-related fash-
ion, with the degree of such reductions dependent upon 
the specific GCS employed. These reductions were deter-
mined to be reversible following cessation of exposure 
to GCS. T6 antigenicity, another cell surface marker of 
human LC, was little affected by GCS exposure. 
Simultaneous immunofluorescent staining for T6 and 
Ia antigenicity within human epidermis of amcinonide-
treated skin dete·cted reduced numbers of T6+ /Ia+ cells 
with a concomittant increase in T6+ /Ia- cells. The data 
presented suggest a selective reduction in the expression 
[1,3]. For many decades attempts were made to fit the dendritic 
LC into one of two already established systems of dendritic 
cells but most authors now believe that LC are mesodermal in 
origin and certainly unrelated to the neural and pigmentary 
systems [ 4,5]. With the acceptance of a mesodermal derivation 
of LC their possible s ignificance was reconsidered and it was 
suggested that LC may represent immunocompetent cells [6], 
capturing antigenic material, and possibly serving as epidermal 
macrophages [7,8]. 
Evidence favoring the concept that LC play a significant role 
in certain immunologic reactions was put forward by Silberberg 
[9] when she reported close apposition of mononuclear lympho-
cyte-like cells to LC within 3-5 h of topical application of 
mercury bichloride, with ultrastructural evidence ofLC damage 
by 6 h. Similar results were obtained at reaction sites with other 
contact allergens (gold chloride, hexachlorophene, mercapto-
benzothiazole, nickel sulfate, paraphenylenediamine, and pyr-
ethrum) and not with contact primary irritants [10]. 
Although the origin and function of LC had been a matter of immunolo ·cally Im ortant receptors and anhgens 15 
LC which may e Involved in sterm -responsive con 
a'Ilerg~c reactiOns. 
- conjecture and theory ever since their discovery by Paul Lan-
gerhans [11], similarities between LC and macrophages have 
been reported recently. These similarities include plasma mem-
brane 5'-adenosine triphosphatase (ATPase) activity [12], abil-
ity to migrate [13], !a-histocompatibility antigens [14,15], Fe 
receptors [16], C3b receptors [17], nonspecific esterase activity 
[18], the ability in vitro to transfer antigen in lymphocyte 
stimulation [19], and bone marrow derivation [4]. The finding 
that the LC of nonsensitized guinea pigs selectively bind certain 
common contact allergens led Shelley and Juhlin [20] to coin 
the term "reticuloepithelial system" for these cells, a system 
that traps and processes external contact allergens, thus playing 
a pivotal role in the primary immune response and in the 
pathogenesis of skin diseases such as contact allergic dermatitis. 
Keratinocytes, melanocytes, and suprabasal dendritic Lan-
gerhans cells (LC) are the 3 populations of cells present in the 
mammalian epidermis. Although the main localization of LC 
under "normal" conditions is the epidermis, where they are 
seen principally in the suprabasal and lower epidermal sites 
[1], they are also seen in much smaller numbers in the dermis 
[2], epithelia of skin appendages, oral and pharyngeal mucosal 
epithelium, esophagus, uterine cervix, lymph nodes, tonsils, and 
thymus, and constitute the infiltrating cells in histiocytosis X 
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The therapeutic mainstay for allergic contact dermatitis is 
the administration of gJucocorticosteroids (GCS), most often 
via epicutaneous application. GCS have been long known to 
suppress delayed hyper-sensitivity in the guinea pig [21] and in 
humans [22] , which is probably due, at least in part, to their 
profound effects on macrophages and monocytes. In addition 
to the ability to suppress inflammation by decreasing mono-
nuclear cell chemotaxis [23] and the inhibition of the response 
to macrophage inhibitory factor and macrophage activating 
factor [24,25], GCS influence macrophage integrity and func-
tion. The expression of human monocyte-macrophage mem-
brane-bound Fe and C3b receptors is diminished following in 
vitro and in vivo exposure to GCS in a dose-dependent fashion 
[26-32]. It has been reported that topical application of beta-
methasone dipropionate (BD) [33] and triamcinolone acetonide 
(AM) [34] to the skin of mice induced an inability to be 
sensitized to dinitrofluorobenzene, and a decrease in immune-
associated (Ia) antigen-bearing LC, respectively. Belsito and 
coworkers [35] have recently shown a decrease in guinea pig 
LC as detected by cell surface ATPase activity and Ia antigen-
icity following exposure to GCS. We report here studies of 
guinea pigs, rats, and humans undertaken to assess the effects 
of in situ exposure to different GCS on the expression of LC Fe 
and C3b receptors and other membrane-bound antigens. 
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MATE RIALS AND METHODS 
Buffers and Tissue Culture Medium 
Sterile minimal essentia l mediu m (ME M) with Earle's salts supple-
mented with 100 un ~ts penicillin/ ml + 2.5 llg amphotericin B/ ml + 100 
uni ts t reptomycin/ ml + 60 llg ty locine/ ml was prepared from stock 
so lu t ions (G rand Island Biological Company, Grand Island, New York ). 
Supplemented ME M was used throughout and is designated as ME M. 
Heat- inactivated fetal calf serum (t.FCS ) was obtained from Gra nd 
Island Biological Co., as was Dulbecco's phosphate- buffered saline 
(PBS), calcium- and magnesium-free. Trypsin (type XI; S igma Chem-
ical Co., St. Louis, Missouri) was sterilized by fil tration through 0.20 
Nalgene fil ters (Na lge Co., Rochester , New York ). Ant ibodies were 
dilu ted in PBS conta ining 5% bovine serum albumin (Cohn fraction V; 
S igma). 
Prep aration of Epidermal Cell S uspensions 
S ingle cell suspensions of Ha rt ley strain guinea pig and ACI strain 
rat epidermal ce lls (G P EC and REC, respectively) were prepared 
according to the method of Sting! et a l [1 41 wi th the minor modifica tion 
that ME M was used instead of T C 199 medium. Resul tant cell suspen-
sions were 98-1 00% viable as determined by trypan blue exclusion. 
Human epidermal cell (HEC) suspensions were similarly prepar ed, 
either from freshly excised neonata l foreskin or from upper ru·m skin , 
wi th the modi fication of an 18-h incubation of 4 oc in 0.5% trypsin in 
PBS. 
Antibodies 
The foll owing antibodies were obtained commercia lly: ra bbi t a nt i-
bovine erythrocyte lgG (Cordis Laborato ries, Mia mi, Florida ), ra bbi t 
a nt isheep erythrocyte IgM (Cordis Laborato ries), monoclonal mouse 
ant ihuman La LgG "" ( 1 mg/ ml; New E ngland Nuclear, Boston, Massa-
chusetts), monoclonal mouse ant ihuman T 6 IgG , (50 llg/ ml; Ortho 
Pharmaceuticals, Ra ri tan, New J ersey ), goat antimouse IgG IgG-FITC 
(F /P = 4.7; Meloy Laboratories, Springfield, Virginia), monoclonal 
mouse antihuman Tl IgG (1 mg/ ml), monoclonal mouse antihuman T 6 
IgG-FITC (Ortho P harmaceut icals), and rabbi t ant imouse lgG IgG-
TRITC (Cappel La b., Cochranville, P ennsylvania). Guinea pig stra in 2 
ant i-guinea pig Ia l.3.7 serum was ra ised by immunization of inbred 
stra in 2 with s train 13 bone marrow cells by an otherwise unmodified 
procedure [36]. Prior to use, this serum was incubated a t 56°C for 30 
min a nd ul tracent rifuged at 100,000 g for 30 min . 
Fe-Mediated R oselle Formation 
One- to 2-day-o ld bovine erythrocytes (BE) collected in citrated 
saline were washed 4 times and resuspended in 4 oc PBS as a 2.5% 
suspension. An equal volume of a 1:20 dilu tion of rabbit ant i-BE lgG in 
PBS was added to the 2.5% BE suspension and incuba ted for 30 min at 
37°C with constant shaking (BEigG ). The cells were then washed 3 
times in 4 oc PBS and resuspended in ME M as a 1% suspension. No 
bound C3 was detected by immunofluorescence. These ce lls were 
incubated at 37°C wi th epidermal ce lls in a 50:1 ra t io, and pelle ted and 
incubated a t 4 °C as described elsewhere [17]. A minimum of 1000 
nucleated cells were coun ted, and those binding~ or more erythrocytes 
were considered to be rosetted. 
Complement-M ediated (C3b) R osette Formation. 
Four- to 5-day-old sheep erythrocytes (SE) collected in cit rated 
saline were washed 4 times and resuspended 'in 4 oc PBS as a 2.5% 
suspension. An equa l volume of 1:10 dilu t ion of rabbit ant i-SE IgM in 
PBS was added to the 2.5% suspension, incubated for 30 min at 37°C 
wi th constant shaking, washed, and sensit ized wit h fresh mouse serum 
(SEigM C') [16]. These cells were then handled and incubated with 
epiderma l ce lls as described a bove for Fc- mediated rosette formation . 
Prep aration of Frozen Shin Sections and Epidermal Sheets 
Six-micron-thick f1·ozen skin sections were prepared using an Amer-
ican Optical cryostat a t -30°C. Incubation of skin samples in 2 M NaBr 
at 37°C for 30 min allowed for ma nual remova l of intact epidermal 
sheets. 
Imnwnoflu orescen.ce 
Fresh preparations of HEC or freshly prepar ed human epidermal 
sheets were incubated in a 1:100 dilution of monoclonal mouse an t ihu -
man Ia lgG"" or a 1:500 di lut ion of monoclonal mouse ant ihuman T 6 
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IgG"" fo r 60 min at 37°C a nd were washed exhaustively in PBS. T he 
samples were then incubated in a 1:10 dilu tion of rabbit a nt imouse lgG 
IgG-FITC fo r 60 min at 37°C and washed in PBS. Fresh preparations 
of Hartley GPEC were handled in an identical fashion with t. guinea 
pig strain 2 ant iguinea pig strain 13 serum fo r the primary incubation 
and staphy lococcal Protein A-FITC for the secondary incubation. Hu-
man epidermal sheets were examined with epiflu orescence microscopy 
and the number of flu orescing dend1·it ic ce lls per 0.5 mm" determined 
using a calibrated reticle. Cytocentrifuge preparations were fu·st viewed 
wi th phase contrast microscopy, and the same field was then examined 
under ul t rav iolet light so that a percentage of flu orescence-posit ive 
cells could be determined. AT least 1000 cells were coun ted fo r each 
determination. S imul taneous detection of T 6 and Ia antigen-bearing 
epidermal cells was achieved as fo llows. Epidermal sheets were seq uen-
tia lly incubated at 37°C fo r 60 min in 1:10 dilu t ion of mouse monoclonal 
ant ihuman Ia IgGt,, 1:20 dilu tion of rabbi t a nt i mouse IgG IgG-TRITC, 
and 1:25 dilution of monoclonal mouse ant ihuman T6 IgG-FITC and 
were washed 3 t imes in P BS fo llowing each incubation. Fluorescing 
cells in 10 400X power fields were enumerated under epifluorescence 
microscopy using appropriate excitation and bar r ier fi lters, and the 
density of the phenotyped cells per 0.5 mm2 calculated. 
In. S itu Exp osure to Ep icuta.neously Applied GCS 
Human: Four X 10 em areas of skin of the medial aspect of opposite 
upper a rms of healthy volunteers were treated epicutaneously twice 
daily for 10 days wi th eit her BD (1 .28 mg/ 2 g whi te petrolatum) or AM 
(2.0 mg/ 2 g hydrophilic base) a nd their respective vehicle (2 g). Subjects 
were between the ages of 18 and 35, of both exes, not pregnant, without 
known medical diseases, and not using a ny prescribed medications. 
Approximately 4 x 5 mm samples of skin were excised under 1% 
lidocaine anesthesia from the treated areas upon completion of appli-
cations, either dispersed epidermal cells or epidermal sheets, and frozen 
sections were prepared and asses ed fo r the pre ence of LC properties; 
a percent control (vehicle) was calculated for each subject. 
Guinea. pig: Opposite flanks of groups of 4 Hartley guinea pigs were 
treated either once daily or twice daily fo r various periods of t ime with 
topical application of either BD (1.28 mg in 2 g petrolatum) or petro-
latum (2 g) . Upon completion of treatment, epidermal cells were 
isolated from opposite flank skin from each guinea pig and t he percent. 
forming roset tes upon incubation with BEi gG (Fe) and SEigMC' (C3b), 
and expressing Ia antigens were determined in triplica te. The values 
obta ined fo r the steroid- t reated fl ank were compa red to those of the 
petrolatum-treated control flank and a percent cont rol for each animal, 
and an average percent control ± SEM fo r the group of 4 guinea pigs 
was calculated. 
R at: Opposite flanks of a pair of ACI stra in rats were treated twice 
daily for 21 days wi th topical application of either BD (1.28 mg in 2 g 
petrolatum) or petrolatum (2 g). At various t imes following discontin-
uance of topical steroid and petrolatum treatments, epidermal cells 
were isolated from opposite flank skin from each rat, and the percent 
forming rosettes upon incubation with BE igG (Fe) and SEigMC' (C3b) 
were determined in triplicate. The values obtained for the steroid-
trea ted flank were compared to those of the petrolatum- treated, contro l 
flank, and a percent control and an average percent cont rol ± SEM 
were calculated. 
RESULTS 
Effects of in Situ Epicutaneous Application. of BD on 
E xpression. of L C Properties by GPEC 
Opposite flanks of Hartley strain guinea pigs were treated 
with either BD or petrolatum. As shown in T able I the percen t 
of epidermal cells, isolated from ED- treated flanks, capa ble of 
formin g Fe and C3b rosettes was decreased from control levels 
as determined with cells isolated from petrolatum-treated 
flanks. More frequent and/ or extended applications of BD 
resulted in more pronounced reductions in LC rosetting. De-
creased Ia expression in BD-treated epidermal cells was de-
tected in those guinea pigs reacting with ant i-guinea pig Ia 1.3.7 
serum. 
In. S itu Epicutan.eous Application of BD and AM Selectively 
Diminishes the E xpression of Certain L C Properties by HEC 
When compared with petrolatum treatment, twice daily ap-
plication of BD (1.25 mg/2 g petrolatum) to upper arm skin (40 
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TABLE I. E ffects of in situ epicutaneous application of BD on 
expression of LC properties by OPEC 
BD application" 
Daily x 9 days 
b.i.d. x 9 days 
b.i.d. X 14 days 
Daily x 20 days 
% Fe rose tted (SEM) 
93.3 (2.3) 
65.2 (2.8) 
39.0 (2.6) 
43.9 (6.1) 
Percent control ( EM) 1' 
% C3b rosetted (SEM) 
93.0 (0.1) 
66.9 (4 .1) 
59. 1 (2.5) 
34.3 (3.4) 
% Ia pos itive'· 
61.5 
47.0 
NR" 
NR 
" Opposite flanks of groups of 4 Hartley guinea pigs were treated 
either once daily or twice daily (b.i .d.) for the indicated number of days 
with topical application of either BD (1.28 mg in 2 g petrolatum) or 
petrolatum (2 g). 
"Upon completion of treatment, epidermal cells were isolated from 
opposite flank skin from each guinea pig and the percent capable of 
forming rosettes upon incubation with BEigG (Fe) and SEigMC' (C3b), 
and expressing Ia antigens were determined in trip licate. The valu es 
obtained for the steroid-treated fl ank were compared to those of the 
petrolatum-treated, contro l flank and a percent contro l calculated. The 
indicated values represent the average percent cont rol (SEM) of the 
group of 4 gu inea pigs. 
,. Expression of certain guinea pig I a antigens was detected by indirect 
immunoflu orescence us ing guinea pig strain 2 ant i-strain 13 serum 
followed by FITC-conjungated staphylococcal Protein A. The epider-
mal cells of 2 guinea pigs reacted under these conditions. 
"Nonreactive. 
TABLE II. Effect of in situ epicutaneous exposure to AM 0.1 % on Ia 
and T6 antigen expression by HEC 
Number of cells PercenL Ave rage perce nt. 
cont.rol control per number of number of cells Subject 'T'reat.me t1t" 0.5 mm"' (SEM) cells (SEM) 
Ia' 1'6' Ia' T6' la_. T6' 
Vehicle 156 (10) 255 (9) 
AM 27 (4) 239 (14) 17.3 93.7 
Vehicle 126 (7) 337 (10) 
AM 32 (5) 266 (11) 25.3 78.9 25.8 (5.1) 90.5 (6.0) 
3 Vehicle 126 (IO) 197 (7) 
AM 44 (4) 195 (6) 34.9 98.9 
" Four x I 0 em areas on the medial aspects of the opposite arms of 3 human 
volunteers were treated twice daily for 10 days with topical applications of either 
AM (2.0 mg in 2 g hydrophilic base) or the hydrophilic base vehicle. 
''Upon completion of treatment, superficial 4 x 5 mm biopsies of treated skin 
were performed. The sk in biopsies were incubated for 30 min at 37°C in 2 N 
NaBr and epidermal sheets prepared. Ia and T6 antigen-bearing LC were detec ted 
by indirect immunoflu orescence employ ing monoclonal mouse antihuman Ia or 
T6 lgG fo llowed by rabbit an limouse lgG-FITC. Fluorescing dendritic cells were 
enumerated, the numbers within steroid-treated skin compared with control-
treated skin , a percent control calculated for each voluntee r, and an average 
percent control (SEM) calculated. 
cm
2
) of 3 volunteers induced parallel reductions in the percent 
of epidermal cells capable of forming Fe rosettes (55.4% ± 2.0 
SEM), forming C3b rosettes (56.6% ± 5.1 SEM), or bearing Ia 
a ntigen (58.8% ± 2.0 SEM) . As shown in T able II, fo llowing 
similar treatment of a second set of volunteers with AM, a 
marked decrease (74.2% ± 5.1 SEM) from control numbers of 
!a-bearing LC was detected in the steroid-treated skin, with the 
number ofT6-bearing LC being only minimally d ecreased (9 .5% 
± 6.0 SEM). Although these findings were suggestive that AM 
induces a selective reduction in expression of Ia a ntige ns, it was 
necessary to determine the degree of the coincidence of Ia and 
T6 a n t igenicity of LC within epidermis following AM a nd/or 
con trol treatments. As shown in Table III, in co ntrol epidermis 
a ll !a-positive cells were also T6-positive (T6+ / l a +) a lthough 
there were T6-positive cells on whic h_ Ia was not detected (T6+ 1 
la- ). In skin treated with AM t he density of T6+ /Ia+ epiderm al 
cells decreased with a concomita nt increase in T6-''/Ia - cells . As 
previously noted (Table II) , the total number of T6-bearing 
cells wa::; only slightly dimin ish ed (a 3.9% reduction from con-
t r ol) , suggesting a selective r eduction in Ia a n t igenic ity. 
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R eversibility of in Situ ED-Induced Reductions in REC Fe 
and C3b Rosette Formation 
Having demonstrated in guinea pigs a nd huma ns a dimin-
ish ed expression of certain LC properties followin g exposure to 
GCS, we attempted to determine t he suscep t ibili ty of rat LC to 
t h ese effects as well as to assess the reversibility of t h ese 
r eductions over time. As shown in Table IV , BD a pplied to 
fl a nks of ACI rats t wice daily for 21 days reduced t h e percent 
of Fe- and C3b-rosetting LC to approximate ly 50% of t hat 
detected in petrolatum-treated control flanks. Within days fol-
lowing discontinuation of steroid a pplication a return of F e- a nd 
C3b-rosetting L C was d etected and petrolatum-treated control 
levels were attained within 28 days. 
DISCUSSION 
The number of immune interactions a nd comp on ents shown 
to be susceptible to the influence of GCS h as m a rkedly in-
creased over t h e past 25 years s ince th e introduction of these 
immunomodula tory compounds. Recognition of t h ese modula-
tory influe nces h as led to the therapeutic use of GCS in a 
va riety of disease states including cell-med iated, contact allergic 
r eactions. Our findings further d eli neate the effects of GCS o n 
the epidermal LC, a pivotal component of the peripheral ann 
of the immune system. W e h ave d etected a d ecrease in epider-
m al cells expressing immunologically important receptors and 
antigens following epicuta n eous exposure to GCS. The degree 
of these r eductions reflected the dose as well as the in trins ic 
clinical and vasoconstrictive potencies of t h e GCS used . Other 
investigators have shown Ia a ntigens on mouse [34] a nd guinea 
TABLE III. Simultaneous detection of T6 and Ia antigen-bearing 
epidermal cells in AM-treated shin 
Epiculaneous 
app li ca tion" 
Hydrophilic 
vehicle 
AM 
Mean number phenotyped cells (SEM)/0.5 mm'" 
TG'/Ia' 
137 (9) 
46 (4) 
203 (10) 
281 (10) 
TG / Ia' 
0 (0) 
0 (0) 
"Four x 1.0 em areas of skin of the media l aspect of opposite upper 
arms of a healthy volunteer were treated twice dai ly for 8 days with 
either AM (2.0 mg/2.0 g hydrophilic base) or its hydrophi lic vehicle 
(2.0 g). 
1
' Epidermal sheets from each area were sequentia lly incubated in 
monoclonal mouse antihuman Ia antigen IgG,,, rabbit ant imouse IgG 
IgG-TRITC, and monoclonal mouse antihuman T6 antigen lgG- FITC, 
and were washed 3 times in PBS following each incubat ion. Fluorescing 
cells in 10 400X power fields were enumerated under epifluorescence 
microscopy, using appropriate excitation and barrier fil ters, and the 
density of the phenotyped cells calculated. Incubation of human epi-
dermis with either rabbit anti mouse IgG lgG-TRITC a lone or following 
prior incubation wi th monoclonal mouse antihuman Tl antigen IgG 
yielded no cellular fluorescence. 
TABLE IV. Return. of Fe and C3b ro;;etting REC following 
discontinuance of in situ epicutaneou.s application ol BD 
Days following 
final application" 
Percent control'' (SEM) 
% P c rose tted % C::J b roset.ted 
0.5 48.5 (4.3) 54.0 (4.0) 
2.5 61.3 (5.2) 63.5 (8.2) 
6.5 64 .7 (2.7) 67.9 (2.1) 
15.5 78.5 (0.7) 78.0 ( 1.9) 
28.5 94.6 (0.1) 99.7 (7.5) 
" Opposite flanks of a pair of ACI strain rats were treated twice daily 
for 21 days wi th topical applications of either BD (1.28 mg in 2 g 
petrolatum) or petro latum (2 g). 
" At the indicated t imes fo llowing discontinuance or topical steroid 
and petrolatum treatments, epidermal cells were isolated from opposite 
flank skin from each rat, and the percenl capable of forming rosettes 
upon incubation with BElgG (Fe) and SEigMC' (C3b) were determined 
in triplicate. The values obta ined for the steroid-treated fl ank were 
compared to those of the petrolatum-treated, control fl ank and a 
percent control (SEM) calculated. 
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pig [35] epidermal LC to be reduced following in situ exposure 
to GCS. Our findings expand this Ia susceptibility to include 
those on human LC. In addition, we have found Fe and C3b 
rosetting by LC isolated from guinea pig, rat, and human 
epidermis to be reduced following GCS exposme. 
The observed reductions in Ia antigen-bearing and Fe- and 
C3b-rosetting epidermal cells do not appear to be due to dis-
appearance of LC since the continued presence of vil·tually all 
T6-positive cells following GCS treatment suggests the persist-
ence of LC. In fact, Belsito et a! [35] observed no ilTeversible 
ultrastructural changes within GCS-treated guinea pig LC. We 
have found similar qualitative ultrastructural changes in GCS-
treated rat epidermal LC (unpublished observations). There-
sults of om quantitative assessment of coincidental Ia and T6 
staining (Table III) support the notion of the continued pres-
ence of LC, with a selective reduction in other immunologically 
important LC markers. 
The immunofluorescent assay for human Ia expression de-
tected approximately 50% of the number of LC determined by 
immunofluorescent detection of human T6 antigen. One could 
speculate that these assays differ in theil· ability to detect two 
different subpopulations of LC: indeterminate LC, which have 
been suggested to be immature LC, and Bil·beck granule-con-
taining LC. The possibility exists that T6 antigens are expressed 
by all LC [37] with the expression of Ia antigens, Fe and C3b 
receptors being restricted to differentiated or activated LC. 
Differences in assay sensitivities as the basis for the differences 
in LC detection cannot be ruled out. 
The loss of Fe- and C3b-rosetting capabilities of LC exposed 
to GCS may indeed be due to a decrease in surface Fe and C3b 
receptors. The addition of GCS does not immediately inhibit 
LC Fe and C3b rosetting and results of indil·ect immunofluo-
rescence testing with aggregated IgG for Fe receptors and of 
testing with a radioimmunochemical assay for C3b receptors 
suggest a reduction in such receptors following in vitro LC 
exposure to GCS [38] . 
In light of our demonstration of the susceptibility of LC Fe 
and C3b rosetting following GCS exposure, experiments dealing 
with LC phagocytosis of, and damage by, immune complexes in 
vivo are interesting [39]. Immune complex uptake by, and 
migration of, epidermal LC appear to be independent of the 
presence of circulating C3 and C4, whereas subsequent LC 
cellular damage, leading to lysosomal disruption, is dependent 
upon the presence of these complement components. The de-
pletion of Fe and C3b receptors following exposure to GCS may 
interfere with LC as targets of immune complex reactions, or 
with LC "activation." 
Finally, GCS perturbation of LC with resultant reduction in 
the number of Ia-bearing LC may allow antigens to escape 
presentation via LC, causing failure to induce [33,40] or elicit 
contact sensitization. 
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